Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, amycretin
Novo Nordisk next-gen shot shows 22% weight loss in early results
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying people with obesity or overweight treated with the drug achieved a 22% weight loss after 36 weeks.
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
Novo Nordisk A/S (NYSE:NVO) released topline results from a phase 1b/2a trial with amycretin intended for once-weekly subcutaneous administration. The trial investigated the safety, tolerability, pharmacokinetics,
12h
on MSN
Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
12h
Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and ...
STAT
10h
Novo Nordisk’s next-generation obesity treatment shows promise in early study
A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Manson won't face charges
Barred from entering DC
27 horses found dead
Giant iceberg on the move
‘Lassie' actor dies at 91
Protections revoked
Cancels scientific meetings
Ex-Nebraska RB Jones dies
Alleged assault cover-up suit
$2.5B wildfire relief package
China's trade status bill
Trump ends security detail
Proposes ending FEMA
Extradition challenge denied
World's most polluted cities
Wins Horse of the Year
Fined over smartwatch burns
Retires from semifinal
Crack down on fake reviews
Bans some tattoos, clothes
Debuts AI assistant
Unveils Operator agent
NBA All-Star Game starters
Newark mayor criticizes raid
Woman indicted in car crash
Millions missed school
Hamas to release 4 hostages
Suspends all trips to Yemen
US home sales fell
Reviews charter schools
Related topics
Wegovy
Glucagon-like peptide-1
Feedback